BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will be presenting at three major healthcare investor conferences in September 2024. The presentations will take place at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4th at 4:05 PM EDT, the 2024 Wells Fargo Healthcare Conference on September 6th at 11:00 AM EDT, and the Baird 2024 Global Healthcare Conference on September 10th at 1:25 PM EDT.

Investors and interested parties can access live webcasts of these presentations through the IR Calendar page on Bio-Techne's Investor Relations website. This series of presentations offers an opportunity for the company to showcase its developments and strategies to a wide audience of healthcare investors and analysts.

MINNEAPOLIS, Aug. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences:

Morgan Stanley 22^nd Annual Global Healthcare Conference
September 4, 2024
4:05 PM EDT

2024 Wells Fargo Healthcare Conference
September 6, 2024
11:00 AM EDT

Baird 2024 Global Healthcare Conference
September 10, 2024
1:25 PM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:

David Clair, Vice President, Investor Relations & Corporate Development david.clair@bio-techne.com 612-656-4416

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-healthcare-conferences-302228184.html

SOURCE Bio-Techne Corporation

FAQ

When is Bio-Techne (TECH) presenting at the Morgan Stanley Global Healthcare Conference in 2024?

Bio-Techne (TECH) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024, at 4:05 PM EDT.

Who will be representing Bio-Techne (TECH) at the upcoming healthcare investor conferences?

Kim Kelderman, President and Chief Executive Officer of Bio-Techne (TECH), will be presenting at the upcoming healthcare investor conferences.

How can investors access Bio-Techne's (TECH) presentations at the healthcare conferences?

Investors can access live webcasts of Bio-Techne's (TECH) presentations through the IR Calendar page on the company's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

What is the date and time of Bio-Techne's (TECH) presentation at the Wells Fargo Healthcare Conference in 2024?

Bio-Techne (TECH) is scheduled to present at the 2024 Wells Fargo Healthcare Conference on September 6, 2024, at 11:00 AM EDT.

When will Bio-Techne (TECH) be presenting at the Baird Global Healthcare Conference in 2024?

Bio-Techne (TECH) will be presenting at the Baird 2024 Global Healthcare Conference on September 10, 2024, at 1:25 PM EDT.